Frédérik Damm

5.6k total citations
58 papers, 2.2k citations indexed

About

Frédérik Damm is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Frédérik Damm has authored 58 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 30 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in Frédérik Damm's work include Acute Myeloid Leukemia Research (46 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Epigenetics and DNA Methylation (11 papers). Frédérik Damm is often cited by papers focused on Acute Myeloid Leukemia Research (46 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Epigenetics and DNA Methylation (11 papers). Frédérik Damm collaborates with scholars based in Germany, France and Netherlands. Frédérik Damm's co-authors include Arnold Ganser, Michael Heuser, Jürgen Krauter, Felicitas Thol, Brigitte Schlegelberger, Katharina Wagner, Gudrun Göhring, Gerhard Heil, Michael Lübbert and Walter Fiedler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Frédérik Damm

56 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédérik Damm Germany 23 1.7k 1.2k 780 492 306 58 2.2k
Brenton G. Mar United States 16 1.5k 0.9× 982 0.8× 667 0.9× 350 0.7× 279 0.9× 33 2.3k
Martin Jädersten Sweden 22 1.7k 1.0× 857 0.7× 795 1.0× 205 0.4× 137 0.4× 63 2.1k
Eva Hellström‐Lindberg Sweden 20 1.5k 0.9× 855 0.7× 758 1.0× 156 0.3× 137 0.4× 29 1.9k
Toshiki Iwai Japan 14 1.3k 0.7× 777 0.7× 519 0.7× 149 0.3× 273 0.9× 36 1.9k
Zhaohui Gu United States 15 808 0.5× 855 0.7× 272 0.3× 262 0.5× 305 1.0× 36 1.4k
Annette Fasan Germany 14 676 0.4× 646 0.6× 299 0.4× 258 0.5× 137 0.4× 34 1.2k
Erica Travaglino Italy 20 2.0k 1.2× 488 0.4× 1.3k 1.6× 107 0.2× 198 0.6× 57 2.3k
Éric Lippert France 23 1.3k 0.8× 968 0.8× 1.4k 1.9× 98 0.2× 109 0.4× 102 2.2k
Henrik Lilljebjörn Sweden 22 673 0.4× 588 0.5× 226 0.3× 264 0.5× 610 2.0× 51 1.6k
Carlos Bueso-Ramos United States 18 1.0k 0.6× 750 0.6× 572 0.7× 76 0.2× 147 0.5× 37 1.7k

Countries citing papers authored by Frédérik Damm

Since Specialization
Citations

This map shows the geographic impact of Frédérik Damm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérik Damm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérik Damm more than expected).

Fields of papers citing papers by Frédérik Damm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédérik Damm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérik Damm. The network helps show where Frédérik Damm may publish in the future.

Co-authorship network of co-authors of Frédérik Damm

This figure shows the co-authorship network connecting the top 25 collaborators of Frédérik Damm. A scholar is included among the top collaborators of Frédérik Damm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérik Damm. Frédérik Damm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walter, Annette O., Benedikt Obermayer, David R. Busch, et al.. (2025). Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma. Journal for ImmunoTherapy of Cancer. 13(4). e010709–e010709. 6 indexed citations
2.
Hablesreiter, Raphael, Friederike Christen, Coral Fustero‐Torre, et al.. (2025). Dynamics of clonal hematopoiesis and cellular responses to stress-induced toxicity in autologous stem cell transplantation. Leukemia. 40(2). 314–324.
3.
Gupta, Manoj Kumar, Tamer T. Önder, Birgit Perner, et al.. (2025). The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPN. Leukemia. 39(10). 2406–2418. 1 indexed citations
4.
5.
Christen, Friederike, et al.. (2024). Detection and Characterization of Clonal Hematopoiesis. Methods in molecular biology. 2865. 449–474. 2 indexed citations
6.
Noerenberg, Daniel & Frédérik Damm. (2024). Beyond the code: the role of histone methylation in cancer resistance and therapy. Signal Transduction and Targeted Therapy. 9(1). 161–161. 6 indexed citations
7.
Williams, Kirsten M., Nancy Gillis, Kelly L. Bolton, et al.. (2023). Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(3). 255–267. 10 indexed citations
8.
Damm, Frédérik, et al.. (2023). Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia. Cancers. 15(18). 4573–4573. 10 indexed citations
9.
Blaschke, Florian, et al.. (2022). Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case report. BMC Cardiovascular Disorders. 22(1). 31–31. 2 indexed citations
10.
Vetter, Valentin Max, Christopher Maximilian Arends, Lars Bullinger, et al.. (2022). Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity. Haematologica. 107(7). 1703–1708. 11 indexed citations
11.
Arends, Christopher Maximilian & Frédérik Damm. (2022). Klonale Hämatopoese und solide Neoplasien. Die Innere Medizin. 63(11). 1133–1140. 1 indexed citations
12.
Christen, Friederike, Raphael Hablesreiter, Kaja Hoyer, et al.. (2021). Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9. Leukemia. 36(4). 1102–1110. 12 indexed citations
13.
Della-Valle, Véronique, Damien Roos‐Weil, Laurianne Scourzic, et al.. (2020). Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice. Blood Cancer Journal. 10(3). 38–38. 10 indexed citations
14.
Sinn, M., Jan Budczies, Frédérik Damm, et al.. (2017). TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study. Annals of Oncology. 28. v251–v251. 3 indexed citations
15.
Reuter, Christoph, Jürgen Krauter, Fredrick O. Onono, et al.. (2014). Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia. Annals of Hematology. 93(6). 977–982. 5 indexed citations
16.
Thol, Felicitas, Frédérik Damm, Katarina Reinhardt, et al.. (2012). Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutations. Genes Chromosomes and Cancer. 51(7). 689–695. 95 indexed citations
17.
Thol, Felicitas, Haiyang Yun, Frédérik Damm, et al.. (2012). Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes. Annals of Hematology. 91(8). 1221–1233. 30 indexed citations
18.
Damm, Frédérik, Felicitas Thol, Birgit Markus, et al.. (2011). Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia. Leukemia. 26(2). 289–295. 31 indexed citations
19.
20.
Moosig, Frank, Frédérik Damm, Matthias Ritgen, et al.. (2006). Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. Clinical & Experimental Immunology. 146(3). 409–416. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brenton G. Mar Breakdown of academic impact, for papers by Martin Jädersten Breakdown of academic impact, for papers by Eva Hellström‐Lindberg Breakdown of academic impact, for papers by Toshiki Iwai Breakdown of academic impact, for papers by Zhaohui Gu Breakdown of academic impact, for papers by Annette Fasan Breakdown of academic impact, for papers by Erica Travaglino Breakdown of academic impact, for papers by Éric Lippert Breakdown of academic impact, for papers by Henrik Lilljebjörn Breakdown of academic impact, for papers by Carlos Bueso-Ramos
Rankless by CCL
2026